Min-Hyo Seo

This inventor holds 27 USPTO granted patents and 4 published patent applications, plus 19 CIPO patents and 18 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Samyang Corporation, Samyang Biopharmaceuticals Corporation, Expression Genetics, Inc.. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min-Hyo Seo. Retrieved from https://idiyas.com/inventor/min-hyo-seo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 27 (Patent Applications = 4)

% Patents Active = 92.6

CIPO Patents = 19

EPO Patents = 18 (Patent Applications = 11)

Average Co-Inventor Count = 3.1

ph-index = 11

Forward Citations = 509(Granted Patents)

Location History:

Taejeon-si, KR (2001)
Seo-ku, KR (2005)
Taejeon, KR (2001 - 2007)
Yongin-si, KR (2020)
Daejeon, KR (1999 - 2022)

Company Filing History:

Samyang Biopharmaceuticals Corporation

patents

1 out of 7

Expression Genetics, Inc.

Samyang Holdings Corporation

patents

6. 1 out of 834,601

Other

patents

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

Anionic Drugs

Cationic Lipids

Polymeric Micelles

Biodegradable Polymers

Sustained Release

Drug Delivery Systems

Hydrophobic Drugs

Amphiphilic Copolymers

Phase Separation

Biodegradable Membranes

Polymeric Nanoparticles

Hydrophilic Block Copolymers

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12752010 - Pharmaceutical composition containing anionic drug, and preparation method therefor (2026-10-06),

2. 11253598 - Pharmaceutical composition containing anionic drug, and preparation method therefor (2022-02-22),

3. 10793516 - Method for selectively synthesizing cationic lipids (2020-10-06),

4. 10456362 - Stabilized pharmaceutical composition and method for preparing same (2019-10-29),

5. 10300063 - Pharmaceutical composition not containing antioxidant and preparation method therefor (2019-05-28),

6. 10292932 - Polymeric micelle particle comprising anionic drugs and method of preparing the same (2019-05-21),

7. 9801818 - Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug (2017-10-31),

8. 9795562 - Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug (2017-10-24),

9. 9522190 - Polymeric nanoparticle solution composition and its manufacturing process (2016-12-20),

10. 9220779 - Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof (2015-12-29),

11. 8853351 - Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof (2014-10-07),

12. 8778322 - pH responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery (2014-07-15),

13. 8021652 - Biodegradable branched polylactide derivatives capable of forming polymeric micelles, and their preparation method and use (2011-09-20),

14. 7879317 - Polymeric micelle compositions with improved stability and methods of making thereof (2011-02-01),

15. 7655735 - Biodegradable multi-block polymeric composition capable of sol-gel transition and pharmaceutical composition comprising the same (2010-02-02),

Title: Innovations in Pharmaceutical Compositions: The Contributions of Min-Hyo Seo

Introduction: Min-Hyo Seo, based in Daejeon, South Korea, is a prominent inventor known for his contributions to pharmaceutical sciences. With an impressive portfolio of 26 patents, Seo has significantly impacted the field through his innovative approaches to drug delivery systems and lipid synthesis.

Latest Patents: Among his latest innovations, Min-Hyo Seo introduced a pharmaceutical composition designed for the delivery of anionic drugs. This composition consists of an anionic drug as the active ingredient, a cationic compound, an amphiphilic block copolymer, and a polylactate. The anionic drug forms a complex with the cationic lipid, which is then encapsulated within a micelle structure created by the amphiphilic block copolymer and the polylactate. Another notable patent involves a method for selectively synthesizing cationic lipids by adjusting the introduction rate of a fatty acid group concerning an oligoalkyleneamine, achieved through careful modification of the reaction conditions.

Career Highlights: Min-Hyo Seo has had a commendable career, with significant roles in companies such as Samyang Corporation and Samyang Biopharmaceuticals Corporation. His work at these institutions has allowed him to further his research and develop cutting-edge innovations in pharmaceutical technology.

Collaborations: Throughout his career, Min-Hyo Seo has collaborated with esteemed colleagues, including In-Ja Choi and Sa-Won Lee. These partnerships have enabled him to expand his research and leverage collective expertise in the advancement of drug delivery systems.

Conclusion: Min-Hyo Seo's contributions to the pharmaceutical field are noteworthy. His innovative patents and collaborations underline his role as a leading inventor in the realm of pharmaceutical compositions and cationic lipid synthesis. As the industry evolves, Seo's work will undoubtedly influence future research and developments in drug delivery mechanisms.

Profile summary based on public USPTO records.